1. Home
  2. CGEN vs MDV Comparison

CGEN vs MDV Comparison

Compare CGEN & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • MDV
  • Stock Information
  • Founded
  • CGEN 1993
  • MDV 2015
  • Country
  • CGEN Israel
  • MDV United States
  • Employees
  • CGEN N/A
  • MDV N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • MDV Transportation Services
  • Sector
  • CGEN Health Care
  • MDV Consumer Discretionary
  • Exchange
  • CGEN Nasdaq
  • MDV Nasdaq
  • Market Cap
  • CGEN 167.4M
  • MDV 147.6M
  • IPO Year
  • CGEN 2000
  • MDV 2022
  • Fundamental
  • Price
  • CGEN $1.53
  • MDV $14.42
  • Analyst Decision
  • CGEN
  • MDV
  • Analyst Count
  • CGEN 0
  • MDV 0
  • Target Price
  • CGEN N/A
  • MDV N/A
  • AVG Volume (30 Days)
  • CGEN 236.0K
  • MDV 108.2K
  • Earning Date
  • CGEN 08-06-2025
  • MDV 08-05-2025
  • Dividend Yield
  • CGEN N/A
  • MDV 8.08%
  • EPS Growth
  • CGEN N/A
  • MDV N/A
  • EPS
  • CGEN N/A
  • MDV N/A
  • Revenue
  • CGEN $27,589,000.00
  • MDV $46,738,000.00
  • Revenue This Year
  • CGEN N/A
  • MDV $2.21
  • Revenue Next Year
  • CGEN $105.77
  • MDV $4.45
  • P/E Ratio
  • CGEN N/A
  • MDV N/A
  • Revenue Growth
  • CGEN N/A
  • MDV N/A
  • 52 Week Low
  • CGEN $1.13
  • MDV $13.62
  • 52 Week High
  • CGEN $2.66
  • MDV $18.11
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 41.35
  • MDV 47.63
  • Support Level
  • CGEN $1.49
  • MDV $14.16
  • Resistance Level
  • CGEN $1.64
  • MDV $14.80
  • Average True Range (ATR)
  • CGEN 0.08
  • MDV 0.25
  • MACD
  • CGEN -0.02
  • MDV 0.00
  • Stochastic Oscillator
  • CGEN 25.00
  • MDV 34.71

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

Share on Social Networks: